A case of Guillain-Barré syndrome following coronavirus disease 2019

2020 ◽  
pp. 10.1212/CPJ.0000000000000917 ◽  
Author(s):  
Pablo Gómez-Porro ◽  
Santiago Valenzuela-Chamorro ◽  
Borja Cabal-Paz ◽  
Carolina Ochoa-López ◽  
Bruno García-Fleitas ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Causal Relationship ◽  
Guillain Barre Syndrome ◽  
Neurologic Complications ◽  
The World ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread around the world since it emerged in Wuhan and coronavirus disease 2019 (COVID-19) has become a pandemic1. There is still little information regarding possible neurologic complications of this spread. Herein, we describe a patient with Guillain-Barré syndrome (GBS) preceded by COVID-19, raising the possibility of a causal relationship.

scholarly journals Guillain-Barré Syndrome associated with the coronavirus disease 2019 (COVID-19)

2020 ◽  
pp. 10.1212/CPJ.0000000000000879 ◽  
Author(s):  
Seyed Amir Ebrahimzadeh ◽  
Abdoreza Ghoreishi ◽  
Nasrin Rahimian
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Respiratory Symptoms ◽  
Guillain Barre Syndrome ◽  
Unknown Etiology ◽  
Neurologic Complications ◽  
Wuhan City ◽  
First Case ◽  
Guillain Barré Syndrome ◽  
Novel Coronavirus ◽  
Guillain Barré

In December 2019, the first case of pneumonia with unknown etiology was reported in Wuhan city, China. The identified pathogen was a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).1 Since then, the virus has spread rapidly worldwide. Although Coronavirus disease 2019 (COVID-19) typically presents with upper or lower respiratory symptoms, there have been rare reports of significant neurologic complications.2,3 Recently, a few reports presented cases of Guillain-Barré syndrome (GBS) after COVID-19.4,5 In this report, we describe 2 cases of GBS that occurred following COVID-19.

scholarly journals SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms

2021 ◽  
Vol 12 ◽  
Author(s):  
Shahrzad Shoraka ◽  
Maria Lucia Brito Ferreira ◽  
Seyed Reza Mohebbi ◽  
Amir Ghaemi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Respiratory System ◽  
Respiratory Symptoms ◽  
Guillain Barre Syndrome ◽  
New Disease ◽  
Neurological Manifestations ◽  
Pathogenic Mechanisms ◽  
The World ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

Since December 2019, the world has been facing an outbreak of a new disease called coronavirus disease 2019 (COVID-19). The COVID-19 pandemic is caused by a novel beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 infection mainly affects the respiratory system. Recently, there have been some reports of extra-respiratory symptoms such as neurological manifestations in COVID-19. According to the increasing reports of Guillain-Barré syndrome following COVID-19, we mainly focused on SARS-CoV-2 infection and Guillain-Barré syndrome in this review. We tried to explain the possibility of a relationship between SARS-CoV-2 infection and Guillain-Barré syndrome and potential pathogenic mechanisms based on current and past knowledge.

scholarly journals Miller Fisher syndrome and COVID-19: is there a link?

2020 ◽  
Vol 13 (8) ◽  
pp. e236419 ◽  
Author(s):  
Amanda Ray
Keyword(s):  
Case Report ◽  
Severe Acute Respiratory Syndrome ◽  
Respiratory Symptoms ◽  
Miller Fisher Syndrome ◽  
Guillain Barre Syndrome ◽  
The Novel ◽  
Fisher Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

Beyond the typical respiratory symptoms and fever associated with severe acute respiratory syndrome, we may still have much to learn about other manifestations of the novel SARS-CoV-2 infection. A patient presented with Guillain-Barré syndrome in China with a concurrent SARS-CoV-2 infection. The following case report looks at a patient presenting with the rare Miller Fisher syndrome, a variant of Guillain-Barré while also testing positive for COVID-19.

History of acute polyradiculoneuropathy (part 2)

Neurology ◽  
2020 ◽  
Vol 94 (19) ◽  
pp. 836-840
Author(s):  
Stéphane Mathis ◽  
Antoine Soulages ◽  
Gwendal Le Masson ◽  
Jean-Michel Vallat
Keyword(s):  
Clinical Entity ◽  
Guillain Barre Syndrome ◽  
Great War ◽  
The World ◽  
Guillain Barré Syndrome ◽  
History Of ◽  
The Rich ◽  
Guillain Barré ◽  
The Great War ◽  
Rich History

First reported by Guillain, Barré, and Strohl during the Great War, the concept of “Guillain-Barré syndrome” (GBS) progressively emerged as a clinical entity in its own right. Despite many debates about its clinical and pathophysiologic characteristics, GBS is now recognized as a disease throughout the world. We describe here the main steps of the rich history of GBS, from 1916 to the present.

scholarly journals Atypical facial onset Guillain-Barré syndrome following first dose of COVISHIELD vaccine

2021 ◽  
Vol 20 (3) ◽  
pp. 379-382
Author(s):  
R.V. Aravinda ◽  
◽  
Priyanka Mahendra Tater ◽  
Harsha Huliyappa ◽  
Christy Joseph Manual ◽  
...  
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Distress Syndrome ◽  
Guillain Barre Syndrome ◽  
Significant Morbidity ◽  
Global Pandemic ◽  
The World ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

In the midst of the global pandemic of COVID-19 and its significant morbidity and mortality reported across the world due to severe acute respiratory distress syndrome (SARS), it has always been posing a new set of complications each passing day. As we are still in the process of understanding about the complications related to COVID-19, we are encountered with complications related to immunization for COVID-19. We are reporting a case of facial onset Guillain-Barré syndrome (GBS) in the patient who received first dose of COVISHIELD vaccine a couple of weeks prior to the onset of his illness.

scholarly journals MANIFESTASI KLINIS NEUROLOGIS PADA COVID-19

2020 ◽  
Vol 3 (3) ◽  
pp. 88-95
Author(s):  
Aurelia Vania ◽  
Desie Yuliani ◽  
I Ketut Sumada
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

Latar Belakang: Coronavirus Disease 2019 (COVID-19) yang disebabkan oleh virus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) merupakan penyakit yang mudah menular dan menyebabkan kondisi pandemi saat ini. Manifestasi utama infeksi SARS-CoV-2 adalah gangguan sistem respirasi, tetapi manifestasi neurologis telah dilaporkan pada beberapa literatur. Tujuan: Untuk menggambarkan manifestasi klinis neurologis yang dapat ditemukan pada pasien COVID-19. Diskusi: Gejala neurologis yang dapat timbul pada COVID-19 bervariasi dari nyeri kepala, dizziness, anosmia, penyakit serebrovaskular, penurunan kesadaran, ensefalitis, meningitis, Guillain-Barré Syndrome, dan gangguan muskuloskeletal. Manifestasi klinis neurologis terkadang muncul mendahului gejala tipikal COVID-19. Simpulan: COVID-19 menyebabkan manifestasi klinis neurologis yang bervariasi dari gejala non-spesifik hingga gejala spesifik yang melibatkan sistem saraf pusat, sistem saraf tepi, dan muskuloskeletal. Infeksi virus ini perlu diwaspadai sebagai penyebab keluhan neurologis di masa pandemi dan manifestasi neurologis baru perlu diantisipasi selama perawatan pasien COVID-19. Kata Kunci: COVID-19, manifestasi neurologis, SARS-CoV-2

scholarly journals COVID-19 vaccine causing Guillain barre syndrome, a rare potential side effect

2021 ◽  
Author(s):  
ahmad matarneh ◽  
alia al-battah ◽  
khalid farooqui ◽  
mohamed ghamoodi ◽  
Mohammed alhatou
Keyword(s):  
Side Effect ◽  
Guillain Barre Syndrome ◽  
Variable Degree ◽  
Potential Side Effect ◽  
The World ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

COVID-19 Virus has affected the world in many ways, resulting in several challenges. COVID 19 vaccines were introduced recently, with a variable degree of immunogenicity and safety. We report a 61-year-old man who had GBS a few days after Receiving The vaccine, his condition improved after 5 days of IVIG

scholarly journals Guillain-Barré Syndrome after COVID-19 Vaccine: Should We Assume a Causal Link?

2021 ◽  
pp. 20-24
Author(s):  
Santvana Kohli ◽  
Mudit Varshney ◽  
Sandeep Mangla ◽  
Binita Jaiswal ◽  
Priyanka H. Chhabra
Keyword(s):  
World Wide ◽  
Economic Status ◽  
Neurological Complications ◽  
Causal Link ◽  
Guillain Barre Syndrome ◽  
Disease Spectrum ◽  
The World ◽  
Guillain Barré Syndrome ◽  
Mass Immunization ◽  
Guillain Barré

The virus SARS-CoV2 and the disease spectrum caused by it have led to a widespread impact on the medical and economic status of all nations of the world. This led to an expedited mission to introduce a vaccine which could attempt to neutralize the pandemic to some extent. Many vaccines have been introduced with an acceptable safety profile, producing only mild adverse effects of soreness at injection site, malaise, fever, diarrhoea, myalgia and uncommonly allergic/anaphylactic reactions and possibility of getting infected with SARS-CoV2. Some isolated reports have also emerged of serious thromboembolic phenomena and neurological complications such as Guillain-Barré Syndrome (GBS). A similar incident was noticed at our institute, where a 71 year old male recipient of COVID-19 vaccine at an immunization centre, presented to us with features of GBS. We hereby report this case, not establishing a direct link between the two, but to raise awareness regarding the ongoing mass immunization world-wide.

Sign in / Sign up

Export Citation Format

Share Document